A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378)
Nom du journal : Eur J Cancer
Année : 2015
Volume : 53
Page de départ : 144
Page de fin : 154